Parvus shows interest in Danish drugmaker that is hunting for new chief following share price slump Source link
Read More »Nordisk
U.S.-listed shares of Novo Nordisk (NVO) are jumping in premarket trading Wednesday even as the Danish pharmaceutical giant lowered its…
Read More »Key Takeaways Hims & Hers Health shares surged Tuesday as the company announced a partnership with Danish drugmaker Novo Nordisk.…
Read More »Key Takeways U.S.-listed shares of Novo Nordisk plunged 7% in intraday trading Thursday after rival Eli Lilly reported positive oral weight-loss…
Read More »Key Takeaways Novo Nordisk is lowering the price of its weight-loss drug Wegovy to $499 per month for some patients…
Read More »KEY TAKEAWAYS Novo Nordisk’s U.S.-listed shares are rising 4% in premarket trading after the Ozempic and Wegovy maker’s better-than-estimated quarterly…
Read More »KEY TAKEAWAYS Novo Nordisk’s U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for…
Read More »